A High-Risk Multiple Myeloma Group Identified By Integrative Multi-Omics Segmentation of Newly Diagnosed Patients

被引：1

作者：

Ortiz, Maria ^{[1
]}

Towfic, Fadi ^{[2
]}

Samur, Mehmet Kemal ^{[3
]}

Flynt, Erin ^{[4
]}

Jang, In Sock ^{[5
]}

Wang, Kai ^{[5
]}

Ashby, Cody ^{[6
]}

Walker, Brian A. ^{[6
]}

Trotter, Matthew ^{[7
]}

Morgan, Gareth ^{[8
]}

Munshi, Nikhil ^{[9
]}

Thakurta, Anjan ^{[2
]}

机构：

[1] CITRE, Res Analyt, Seville, Spain

[2] Celgene Corp, Summit, NJ USA

[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA USA

[4] Celgene Corp, Translat Dev & Diagnost, Summit, NJ USA

[5] Celgene Corp, Res Analyt, San Diego, CA USA

[6] Univ Arkansas Med Sci, Myeloma Inst, Little Rock, AR 72205 USA

[7] CITRE, Seville, Spain

[8] Myeloma Inst Res & Therapy, Little Rock, AR USA

[9] Harvard Med Sch, Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA USA

来源：

关键词：

D O I：

10.1182/blood-2018-99-117114

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3165

引用

页数：2